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ABSTRACT 
Introduction: Hyperlipidaemia and insulin resistance may have a relationship. Most of the 
previous studies looked at insulin resistance in hyperlipidaemic subjects who were also 
obese. So influence of obesity and hyperlipidaemia acted simultaneously in the genesis of 
insulin resistance. 
Objective: To determine insulin sensitivity and secretory status of non-obese 
normoglycemic Malay subjects, and to study the relationship between hyperlipidemia and 
insulin sensitivity in such population. 
Methodology: A cross sectional study on 246 non-obese (BMI<25kg/m2, waist 
circumference male<102cm, female <88cm.) and non-diabetic subjects age between 30-
60 years was carried out. Fasting plasma glucose, fasting insulin and lipid profile were 
done. Insulin sensitivity and secretory status was calculated using homeostasis model 
assessment (HOMA) software (HOMA%S, HOMA%B and HOMA-IR). The subjects 
were divided into two groups according to their lipid status (128 normolipidemic and 118 
hyperlipidemic) and their insulin sensitivity was compared. 
Results: The hyperlipidemic subjects showed substantially lower insulin sensitivity and 
higher insulin resistance in comparison to normolipidemic subjects. The mean of 
HOMA%S of hyperlipidemic and normolipidemic subjects were 80 and 155 (p<.0001) 
respectively. The mean of relative insulin resistance HOMA-IR was 2.66 in 
hyperlipidemic subjects which was 1.05 in normolipidemic subjects. Insulin secretory 
status (HOMA%B) oftwo group were 178 and 116 respectively. 
Conclusion: Insulin sensitivity of otherwise healthy non-obese hyperlipidemic 
subjects is lower than normolipidemic subjects. The B cells of hyperlipidemic subjects 
have to work more to compensate lowered insulin sensitivity. 
Key words: insulin sesnsitivity, HOMA%S, HOMA%B, HOMA-IR 
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INTRODUCTION 
Insulin resistance is a common phenomenon and plays a central role in the pathogenesis 
and clinical course of several human diseases. It is also associated with various metabolic 
and physiological abnormalities including obesity, hypertension, hyperlipidaemia and 
glucose intolerance (Boden, 2001 ). Its relation with obesity is established and a wealth of 
epidemiological studies has been done in exploring and explaining this relationship 
(Lillioja and Bogardus, 1988; Ferrannini et a/, 1997; Kahn, 2003). It is also associated 
with hyperlipidaemia (Defronzo and Ferrannini, 1991 ). Hyperlipidaemia and insulin 
sensitivity have an interaction, whether insulin resistance is secondary to hyperlipidaemia 
or hyperlipidaemia follows insulin resistance the matter is yet to be known (Reaven, 
1988; Doherty eta/, 1997). 
Most of the previous studies on insulin sensitivity were performed on hyperlipidaemic 
subjects who were also obese. So influence of obesity and hyperlipidaemia acted 
simultaneously in the genesis of insulin resistance. 
Importance of the present study: 
It seems important to note that even modest change in lipid status may influence insulin 
sensitivity very much. Studies indicate that the metabolic syndrome is becoming a rapidly 
rising non-communicable disease around the world. Especially its prevalence rising with 
improvement of economic and social status of peoples of the developing countries as well 
as in developed countries. Study done by Mafauzy et al in 1999 shows that 57% of 
normal Malay subjects are hypercholesterloemic. Studies also show high prevalence of 
other features of metabolic syndrome in Malaysia, e.g. obesity ( 43-52% are either 
overweight or obese), hypertension (10-37%), hyperlipidemia (63-76%) (Mustaffa, 
2004). 
So far the metabolic syndrome as a whole is being discussed much. But it is still unsettled 
whether this syndrome represents a fortuitous cluster of metabolic features or whether 
insulin resistance itself is the common etiological factor behind all features of the 
syndrome (Sum et a/, 1992). It is also unclear whether insulin resistance is present in 
each feature of the disease. If it is established by research we can come to conclusion that 
hyperinsulinemia or insulin resistance is the aetiological link between other features of 
metabolic syndrome. So we plan to isolate a group of people who are otherwise normal 
(i.e. free from all features of MS) but having only hyperlipidemia and then study their 
insulin sensitivity in order to find out the linkage between lipid abnormalities and insulin 
sensitivity. 
METHODOLOGY 
Study Design 
This cross-sectional study was conducted from mid September 2003 to March 2005 
which involved both outdoor and on-campus laboratory-based activities. Research 
volunteers were recruited from schools and public offices in Kota Bharu, the capital city 
of the state of Kelantan in northeastern peninsular West Malaysia. We circulated an open 
notice to all staffs at each location to invite them in our initial screening program. 
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Selection Criteria 
Inclusion criteria were: 1) age between 30 to 60 years, 2) non-obese with BMI less than 
25kg/m2 and waist circumference in males less than 1 02cm and less than 88cm in females 
(NCEP ATPIII, 2001), 3) non-diabetic and non-hypertensive, 4) without family history of 
type 2 diabetes, and 5) non-smoker. Subjects suffering from chronic illnesses, ketosis, 
chronic liver and renal diseases, and pregnant women were excluded from the study. 
Subjects taking anti-hypertensive drugs, steroids or hormonal products were also 
excluded (Boden, 2001). 
Ethical Clearance 
The study was approved by the Research and Ethics Committee, School of Medical 
Sciences, Universiti Sains Malaysia (USM). Written informed consent was taken from 
every participant of the study. The study method adhered to the existing Malaysian 
guidelines for International Committee on Harmonization of Good Clinical Practice 
(ICH-GCP) Guidelines (GCP, 1999). All essential source documents required in this 
study were handled according to Malaysian GCP Guidelines ( 1999). 
Recruitment of Subjects 
We screened the subjects according to the selection criteria, anthropometric 
measurements (height, weight, waist circumference, BMI) and clinical history. Those 
who met the selection criteria were invited to come to the Department of Chemical 
Pathology in USM after overnight fasting (10-12 h) for oral glucose tolerance test 
(OGTT), liver function test (LFT), renal function test (RFT) followed by lipid levels and 
insulin sensitivity test in two separate visits. 
Anthropometry and Blood Pressure 
Body weight (in kilogram) was measured in patients wearing light clothing. Height in 
centimeter (em) was measured using Standard ZT-120®, (Healthometer Inc., USA) with 
bare foot. Body mass index (BMI in kg/m2) of the subjects was calculated as weight in 
kilogram divided by height in square meter. Waist circumference (in em) was taken at the 
level of umbilicus (Meigs eta!, 2003). Hip circumference was measured at the maximal 
extension of the buttocks (Ford eta!, 2003). Waist-to-hip ratio (WHR) was calculated as 
the ratio of waist circumference to hip circumference. 
Pulse and blood pressure of every subject were measured by the same physician. At least 
two readings of blood pressure were taken at 5 minutes interval on the right hand using a 
mercury sphygmomanometer (Baumanometer®, W.A. Buam Co, Inc., New York, USA) 
in the sitting position and the mean value was noted. A person was identified as 
hypertensive if he either had a systolic blood pressure at or above 140 mmHg (~ 140 
mmHg) and/or diastolic blood pressure at or above 90 tnmHg (~90 mmHg) (MOH,CPG, 
2002). 
Phlebotomy and Biochemical Tests 
Blood specimens for LFT, RFT and lipids were collected in 5ml Vacutainer® tubes with 
SST® Gel and clot activator, that for insulin in 5ml plain Vacutainer® tubes, and for 
glucose in 2ml fluoride oxalate tubes (NAF OXALATE 2~. OGTT was performed using 
75gm of anhydrous glucose made up to 250ml of solution with plain water. Diabetes and 
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Impaired Glucose Tolerance (IGT) were defined according to the criteria set by the WHO 
Expert Committee (WHO, 2003). Plasma glucose and lipid levels were performed on the 
same day of collection. Serum for insulin was frozen immediately at -80 o C and was 
assayed within three months of specimen collection. 
Selection of Groups for Comparing Insulin Sensitivity 
Based on the results of lipid profile of the subjects, they were divided into two groups, 
hyperlipidemic and normolipidemic groups, based on the criteria of NCEP A TP III 
(200 1 ). A person was defined as hyperlipidemic if his blood cholesterol level was 
2:5.18mmol/L and/or his triglyceride (TO) level was 2:1.71mmol/L. 
The insulin sensitivity of both groups was compared based on HOMA parameters. 
Laboratory Analyses 
Laboratory analyses were performed in the Department of Chemical Pathology 
Laboratory and Department of Medicine Endocrine Laboratory. Both laboratories are 
IS0-900 1 certified . 
Plasma glucose was estimated by the glucose oxidase (GOD-PAD) method using 
commercial kits from ROCHE®, Switzerland and Roche Cobas Integra 400® automated 
chemistry analyzer (Switzerland), with an inter-assay coefficient of variation (CV) of 
2.45%. 
Serum total cholesterol (interassay CV 1.27%), HDL cholesterol (HDL-C) (interassay 
CV 1.26%) and triglyceride (interassay CV 1.38%) were measured by automated fully 
enzymatic colorimetric method using commercial kits from ROCHE® and using Roche 
Cobas Integra 400® automated chemistry analyzer. The LDL cholesterol (LDL-C) level 
in serum was calculated by using the Friedewald formula (Friedwald, 1972). Very low 
density lipoprotein (VLDL) cholesterol was calculated by dividing TG level by 2.2. 
Serum insulin was measured by chemiluminescence method using commercial reagent 
IMMULITE (Diagnostics Products Corporation EURO/DPC, United Kingdom) using 
IMMULITE® analyzer (interassay CV 1.39o/o). 
Homeostasis Model Assessment (HOMA) 
Homeostasis model assessment (HOMA) software was used to calculate insulin 
sensitivity (HOMA%S) and insulin secretory capacity (HOMA%B) of the subjects. 
Fasting insulin levels (in pmol/L) and fasting plasma glucose(FPG) (in mmol/L) were 
keyed into the computer using the HOMA software to calculate HOMA%S and 
HOMA%B (Matthews eta/, 1985; Hermans eta/, 1999). 
HOMA for insulin resistance (HOMA-IR) was also calculated manually using the 
following formula in order to compare the results of this study with those of previous 
studies. 
HOMA-IR = (fasting insulin in J.!lU/ml X fasting glucose )/22.5 
Statistical Analyses 
Statistical analysis were done using statistical package for social sciences (SPSS) for 
Windows version 11.0 (SPSS Inc, 2000). 
subjects demographic, anthropometric and biochemical (lipid, FPG, insulin sensitivity) 
baseline descriptive statistics were presented as percentage, mean (sd) and median (iqr) 
ro 
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whenever appropriate.Independant t test or Mann Whitney test was used for comparing 
numerical data. Correlation between insulin sensitivity and different lipid types were 
expressed as Pearsons/Spearman coefficient according to data distribution. The 
relationship between lipid status and insulin sensitivity was determined with ANCOVA 
to adjust the possible effect of age, sex, BMI and waist circumference. 
RESULTS 
Characteristics of study subjects 
From a total of 890 people of different school and public office of KotaBharu a total of 
561 subjects participated (Participation rate 63%) in the random screening program 
according to the selection criteria of this study. Of this, 246 person fulfilled the selection 
criteria; 128 (52.03%) were normolipidemic and 118 (47.97%) were hyperlipidemic. 
Mean BMI, waist and hip circumference and WHR of the hyperlipidemic group was 
significantly higher than the normolipidemic group (Table 1 ). 
Lipid levels of two different groups 
TG, LDL-C, VLDL and total cholesterol of the hyperlipidemic group were significantly 
higher than in the normolipidemic group. However, the HDL cholesterol of the female 
hyperlipidemics was not significantly lower than that of the normolipidemic subjects 
(Tables 2 and 3). 
Fasting glycemia and insulin sensitivity status 
The median insulin sensitivity of normolipidemic male Malay subjects aged between 30-
60 years expressed as HOMA%S was 141.70% compared to 68.30% (p<0.001) in 
hyperlipidemic subjects. HOMA%S for female normolipidemic and hyperlipidemic 
subjects was 151.30% and 70.10% respectively (p<O.OOl). 
The median insulin resistance expressed by HOMA-IR was 1.05 for male non-obese, 
normolipidemic Malay subjects. For hyperlipidemic subjects, this value was as high as 
2.17 (p<O.OO 1 ). For female normolipidemic and hyperlipidemic subjects these two value 
were 0.95 and 2.21, respectively (p<0.001). 
Fasting insulin level was significantly higher in the hyperlipidemic male and female 
subjects compared to normolipidemics (Tables 4 and 5). 
Correlation between insulin sensitivity and lipid status 
Statistical correlation tests were performed between insulin sensitivity with TG, HDL-C, 
LDL-C, VLDL and total cholesterol. Insulin sensitivity (HOMA%S) showed negative 
correlation with total cholesterol (r= -0.533, p<0.001) and TG (r= -0.313, p<0.001), LDL 
cholesterol (r= -0.407, p<O.OO 1) and VLDL cholesterol (r= -0.311, p<O.OO 1 ), positive 
correlation with HDL cholesterol (r=0.260, p<O.OO 1) (Table 6). 
Association of lipid status with insulin sensitivity 
There were significant difference in insulin sensitivity, relative insulin resistance and 
insulin secretory capacity between two groups based on lipid status {p<0.001) {Table 7). 
It was also seen that age, sex, BMI and waist circumference was not significant predictor 
of insulin sensitivity status among non-obese subjects. 
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DISCUSSION 
We found that the insulin sensitivity of hyperlipidemic Malay subjects was significantly 
lower and their relative insulin resistance was significantly higher than normolipidemic 
(adjusting for age, sex, BMI and waist circumference). 
Previous studies on insulin sensitivity involved peoples of all BMI range, so the insulin 
sensitivity or resistance we got from those studies not always mention the insulin 
sensitivity of a healthy population (Tai et al, 2000; Tan et al, 1999; Haffner et al, 1997). 
In studies involving Malay partcipants in Singapore (Tai et al, 2000; Tan eta/, 1999), the 
mean HOMA-IR was 1.48 for male (n = 254) and 1.63 for female (n = 254) participants, 
obese people was also included in the study. The median HOMA-IR of Bruneck study 
(Bonora eta/, 1988) people was 2.51 (n=888, including diabetic and obese people too). In 
another study (Haffner et a/, 1997) involving Mexican-Americans and Non-Hispanic 
whites mean HOMA-IR of Mexican-Americans were3.83 and non-Hispanic whites were 
2.56 (population included diabetic, IGT and obese people also). In comparison to these 
studies our study represents non-obese, normoglycemic Malay subjects and adjusted for 
the possible confounders of age, sex, BMI, waist circumference. So the insulin sensitivity 
of notmolipidemic population of this study represents the insulin sensitivity of normal 
Malay population and it's different than Malays of Singapore, probably difference 
between lifestyle may responsible behind this difference. 
We found that lipid status is associated with insulin sensitivity in non-obese subjects 
other than age, sex, BMI and waist circumference. Previous studies relating BMI with 
insulin sensitivity have simply used BMI as a measure of relative body size or obesity 
without considering that people with similar BMI may have widely varying distribution 
of their adipose tissue (Y oshitomi et a/, 2005). Though there were many studies showing 
higher insulin resistance among male but when it was adjusted for other confounders 
than it showed no influence of sex, Ferrannini eta! and Barbieri eta/ also reported of 
founding no difference in insulin sensitivity and resistance between male and female. 
Ferrannini eta/ also conclude that in healthy Europeans, age per se is not a significant 
cause of insulin resistance. 
The insulin secretory capacity as expressed by HOMAo/o-B of hyperlipidemic subjects 
was higher than the normolipidemic subjects. It indicates that they face a higher 
challenge to meet the lowered insulin sensitivity so they need to secret more insulin to 
compensate lowered insulin sensitivity. 
Our observation was that even moderate change in lipid status in non-obese subjects 
influence insulin sensitivity and secretion. These findings have clinical importance as 
these clinical conditions in non-obese subjects are often ignored and they remain 
untreated. 
CONCLUSION 
Insulin sensitivity of otherwise healthy non-obese hyperlipidemic subjects is lower, and 
their insulin secretion is more to compensate for the lowered insulin sensitivity, in 
comparison with normolipidemic subjects. Insulin sensitivity decreases with increasing 
TG, LDL-C and total cholesterol. It has positive correlation with HDL-C level. Even 
modest dyslipidemia in non-obese people should be managed with priority for the 
prevention of metabolic syndrome in future. 
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Table 1. Demographic and anthropometric characteristics of246 Malay study subjects 
• 
Demographic variable Normolipidemic Hyperlipidemic pa 
* 
(n = 128) (n = 118) 
Mean age (yrs) 
Male 39.43 (6.42) 43.03 (7.79) 0.014 
Female 37.75(6.36) 41.65 (7.12) 0.001 
Sex 
Male 44 (43.14%) 58 (56.86%) 
Female 84 (58.33%) 60 {41.67} 
BMI* 
Male 22.41 (2.16) 23.77 (2.12) <0.001b 
Female 21.83 (2.50) 23.91 (2.14) <0.001 b 
Waist 
Male 81.28 (7.34) 89.74 (7.30) <0.001 
Female 72.34 (8.17) 78.40 (7.85) <0.001 
Hip 
Male 94.73 (5.45) 100 (6.03) <0.001 
Female 94.04 (8.40) 97.95 (7.81) <0.001 
WHR 
0 Male 0.85 (0.05) 0.89 (0.04) <0.001 
Female 0.77 (0.06) 0.80 (0.05) <0.001 
9 lndependent Student's t test, *Median (iqr), 6Mann-Whitney test 
Table 2. Lipid profile of the different groups of Malay males 
Normolipidemic Hyperlipidemic 
Parameter n=44 n=58 p-value8 
Cholesterol* 4.89 (0.35) 6.52 (0.96) <0.001 b 
Tg 1.10 (0.33) 2.40 (1.74) <0.001 
... 
HDL-C 1.40 (0.25) 1.31 (0.43) 0.014 
1\ LDL-C 2.98 (0.38) 4.18 (1.01) <0.001 
VLDL 0.50 (0.15) 1.09 (0.79) <0.001 
8 lndependent Student's t test, *Median (iqr), bMann-Whitney test, (values are in mmol/L) 
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Table 3. Lipid profile of the different groups of Malay females 
• 
Normolipidemic Hyperlipidemic 
-II Parameter n=84 n=60 p-value8 
Cholesterol* 5.08 (0.52) 6.30 (1.26) <0.001 6 
Tg 0.85 (0.33) 1.59 (0.92) <0.001 
HDL-C 1.73 (0.45) 1.62 (0.37) 0.157 
LDL-C 2.81 (0.58) 3.96 (0.81) <0.001 
VLDL 0.39 (0.15) 0.72 (0.42) <0.001 
8 lndependent Student's t test, *Median (iqr), 6Mann-Whitney test, (values are in mmol/L) 
Table 4. Fasting glycemia and insulin sensitivity status of Malay males 
Parameter Normolipidemic Hyperlipidemic p-value3 
n=44 n=58 
Mean (SO) Mean (SO) 
FPG {mmoi/L) 4.35 (0.87) 4.50 (0.83) 0.05 
Insulin {~moi/L) 33.60 (12.90)* 72.60 (65.40)* <O.OOlb 
HOMA0/oS 141.70 (59.87)* 68.30 (69.20)* <O.OOlb 
HOMA%B 97.60 (61.52)* 166.70 (123.50}* <O.OOlb 
HOMA-IR 1.05 (0.54)* 2.17{2.24)* 1 <O.OOlb 
3 lndependent Student's t test, *Median (iqr), bMann-Whitney test 
u 
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Table 5. Fasting glycemia and insulin sensitivity status of Malay females 
Parameter Normolipidemic Hyperlipidemic p-valuea 
n=84 n=60 
Mean (SO) Mean (SO) 
FPG {mmol/L) 4.09 {0.56} 4.45 {0.66} <0.001 
Insulin {~moi!L} 32.40 (19.50}* 68.1 0 ( 43 .05)* <O.OOlb 
HOMA0/oS 151.30 (80.40)* 70.10 {36.45)* <O.OOlb 
HOMA%B I 06.55 (51.52)* 151.60 (89.72)* <O.OOlb 
HOMA-m 0.95 (0.52)* 2.21 ( 1.89)* <O.OOlb 
8 lndependent Student's t test, *Median (iqr), bMann-Whitney test 
Table 6. Correlation between insulin sensitivity index (HOMA %S) with lipids in 246 
non-obese, normoglycemic Malay subjects. 
Parameter n r p-value 
Total cholesterol 246 -0.533* <0.001 
LDL-Ca 239 -0.407 <0.001 
HDL-C 246 0.26 <0.001 
VLDL 246 -0.311 <0.001 
Tg 246 -0.313 <0.001 
*Spearman's correlation coefficient, aLDL-C of7 subjects was not calculated using 
Friedwald formula because TG was higher than 4.5 mmol/L. 
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Abstract 
The relationship between insulin sensitivity and hyperlipidemia in normal 
bodyweight normoglycemic subjects is not well-studied. We were interested to 
study the insulin sensitivity of non-obese normoglycemic Malay subjects free from 
other confounders that may influence insulin sensitivity (i.e. obesity, glucose 
intolerance and hypertension) and to find its relation with lipid status. A cross-
sectional study was performed on 246 non-obese and non-diabetic subjects aged 
between 30-60 years. Fasting plasma glucose, fasting insulin and lipid profile were 
determined. Insulin sensitivity and secretory status were calculated using the 
homeostasis model assessment (HOMA) software (HOMA%8, HOMA%B and 
HOMA-IR). The subjects were divided into normolipidemic and hyperlipidemic 
groups based on their lipid status and their insulin sensitivity was compared. The 
insulin sensitivity (HOMA%S) of hyperlipidemic subjects was 80.72%, HOMA-IR 
was 2.66 and HOMA %B was 178.51%, these values were significantly different in 
normolipidemic subjects, their HOMA %8 was 155.17%, HOMA-IR was 1.05 and 
HOMA%B was 116.65% (p<0.001)(values adjusted for age, sex, BMI and waist 
circumference). Our observation was that the insulin sensitivity of otherwise healthy 
non-obese hyperlipidemic subjects was lower in comparison with normolipidemic 
subjects. We conclude that dyslipidemia in non-obese people should be managed 
with priority for the prevention of metabolic syndrome in future. 
Key words: 
Insulin sensitivity, insulin secretory status, HOMA%8, HOMAo/oB, HOMA-IR 
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INTRODUCTION 
Insulin sensitivity is the sensitivity of the tissues (especially hepatic and skeletal) to 
the actions of insulin. It is influenced by age, body mass index (BMI), abdominal 
obesity, level of physical activity and different metabolic and endocrine factors [I]. 
Originally it was discussed in connection with the pathogenesis of type 2 diabetes 
but in his Banting lecture [2], Reaven connected it with many metabolic disorders 
such as glucose intolerance, dyslipidemia, hyperuricemia and hypertension. Further 
research established this concept with more evidence [1-4]. Its relation with obesity 
is established and a wealth of epidemiological studies has been done in exploriL~g 
this relationship [1 ,5-7]. It is also associated with hyperlipidemia [4]. 
Hyperlipidemia and insulin resistance have a complex interaction. Whether insulin 
resistance is secondary to hyperlipidemia or hyperlipidemia follows insulin 
resistance the matter has yet to be resolved [2, 8]. Most of the previous studies on 
insulin sensitivity were performed on hyperlipidemic subjects who were also obese 
[9] as a result both effect of obesity and hyperlipidemia acted simultaneously in 
genesis of insulin resistance. In an attempt to study the relationship between insulin 
sensitivity and lipid status, we were interested to isolate a group of subjects who 
were free from possible factors (e.g., obesity, glucose intolerance, hypertension) 
which influenced insulin sensitivity and to compare their insulin sensitivity 
according to their lipid status. 
"2./ 
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METHODOLOGY 
(a) Study Design 
This cross-sectional study was conducted from mid September 2003 to March 2005 
which involved both outdoor and on-campus laboratory-based activities. Research 
volunteers were recruited from schools and public offices in Kota Bharu, the capital 
city of the state of Kelantan in northeastern peninsular West Malaysia. We 
circulated an open notice to all staffs at each location to invite them in our initial 
screening program. 
(b) Selection Criteria 
Inclusion criteria were: 1) age between 30 to 60 years, 2) non-obese with BMI less 
than 25kg/m2 and waist circumference in males less than 1 02cm and less than 88cm 
in females [10], 3) non-diabetic and non-hypertensive, 4) without family history of 
type 2 diabetes, and 5) non-smoker. Subjects suffering from chronic illnesses, 
ketosis, chronic liver and renal diseases, and pregnant women were excluded from 
the study. Subjects taking anti-hypertensive drugs, steroids or hormonal products 
were also excluded [ 1]. 
(c) Ethical Clearance 
The study was approved by the Research and Ethics Committee, School of Medical 
Sciences, Universiti Sains Malaysia (USM). Written informed consent was taken 
from every participant of the study. The study method adhered to the existing 
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Malaysian guidelines for International Committee on Harmonization of Good 
Clinical Practice (I CH -GCP) Guidelines [ 11]. All essential source documents 
required in this study were handled according to Malaysian GCP Guidelines ( 1999). 
(d) Recruitment of Subjects 
We screened the subjects according to the selection criteria, anthropometric 
measurements (height, weight, waist circumference, BMI) and clinical history. 
Those who met the selection criteria were invited to come to the Department of 
Chemical Pathology in USM after overnight fasting (10-12 h) for oral glucose 
tolerance test (OGTT), liver function test (LFT), renal function test (RFT) followed 
by lipid levels and insulin sensitivity test in two separate visits. 
(e) Anthropometry and Blood Pressure 
Body weight (in kilogram) was measured in patients wearing light clothing. Height 
in centimeter (em) was measured using Standard ZT -120®, (Healthometer Inc., 
USA) with bare foot. Body mass index (BMI in kg/m2) of the subjects was 
calculated as weight in kilogram divided by height in square meter. Waist 
circumference (in em) was taken at the level of umbilicus [12]. Hip circumference 
was measured at the maximal extension of the buttocks [13]. Waist-to-hip ratio 
(WHR) was calculated as the ratio of waist circumference to hip circumference . 
Pulse and blood pressure of every subject were measured by the same physician. At 
least two readings of blood pressure were taken at 5 minutes interval on the right 
hand using a mercury sphygmomanometer (Baumanometer®, W.A. Buam Co, Inc., 
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New York, USA) in the sitting position and the mean value was noted. A person was 
identified as hypertensive if he either had a systolic blood pressure at or above 140 
mmHg (~ 140 mmHg) and/or diastolic blood pressure at or above 90 mmHg (~90 
mmHg) [14]. 
(f) Phlebotomy and Biochemical Tests 
Blood specimens for LFT, RFT and lipids were collected in 5ml Vacutainer® tubes 
with SS~ Gel and clot activator, that for insulin in 5ml plain Vacutainer® tubes, and 
for glucose in 2ml fluoride oxalate tubes (NAF OXALATE 2®). OGTT was 
performed using 75gm of anhydrous glucose made up to 250ml of solution with 
plain water. Diabetes and Impaired Glucose Tolerance (IGT) were defined 
according to the criteria set by the WHO Expert Committee [15]. Plasma glucose 
and lipid levels were performed on the same day of collection. Serum for insul1n 
was frozen immediately at -80oC and was assayed within three months of specimen 
collection. 
(g) Selection of Groups for Comparing Insulin Sensitivity 
Based on the results of lipid profile of the subjects, they were divided into two 
groups, hyperlipidemic and normolipidemic groups, based on the criteria of NCEP 
A TP III [ 1 0]. A person was defined as hyperlipidemic if his blood cholesterol level 
was ~5.18mmol/L and/or his triglyceride (TG) level was ~1.7lmmol/L. 
The insulin sensitivity of both groups was compared based on HOMA parameters. 
